| Formation | 1969 |
|---|---|
| Type | Medical association Professional association |
| Headquarters | 230 W. Monroe, Suite 710 |
| Location | |
Membership | > 2,000 |
| David E. Cohn, MD, MBA | |
Key people | Pierre Désy, MPH, CAE Chief Executive Officer |
| Website | http://www.sgo.org/ |
The Society of Gynecologic Oncology (SGO), headquartered in Chicago, Illinois, is the premier medical specialty society for health care professionals trained in the comprehensive management of gynecologic cancers, affecting the uterus, fallopian tubes, ovaries, cervix, vagina, and vulva. As a 501(c)(6) organization, the SGO contributes to the advancement of women's cancer care by encouraging research, providing education, raising standards of practice, advocating for patients and members and collaborating with other domestic and international organizations.
SGO has 2,000 members representing the entire gynecologic oncology team in the United States and abroad. Members include primarily gynecologic oncologists, as well as medical oncologists, pathologists, radiation oncologists, hematologists, surgical oncologists, obstetrician/gynecologists, nurses, physician assistants, social workers, fellows, residents and other allied health care professionals interested in the treatment and care of women's cancer. They regularly at the Annual Meeting on Women's Cancer.
SGO members provide multidisciplinary cancer treatment including chemotherapy, radiation therapy, surgery and palliative care. They practice in a variety of settings, including academic institutions and hospitals, major regional cancer centers and private practice.[1]
Gynecologic Oncology, published by Elsevier, is the official medical journal of SGO. It has an Impact Factor of 4.623 as of 2019.